ATE369371T1 - 1-azadibenzoazulene als inhibitoren der produktion von tumornekrosefaktor und zwischenprodukte für deren herstellung - Google Patents
1-azadibenzoazulene als inhibitoren der produktion von tumornekrosefaktor und zwischenprodukte für deren herstellungInfo
- Publication number
- ATE369371T1 ATE369371T1 AT03752868T AT03752868T ATE369371T1 AT E369371 T1 ATE369371 T1 AT E369371T1 AT 03752868 T AT03752868 T AT 03752868T AT 03752868 T AT03752868 T AT 03752868T AT E369371 T1 ATE369371 T1 AT E369371T1
- Authority
- AT
- Austria
- Prior art keywords
- production
- azadibenzoazulene
- inhibitors
- necrosis factor
- tumor necrosis
- Prior art date
Links
- ORXLWJFOESJIGJ-UHFFFAOYSA-N 5-azatetracyclo[12.4.0.02,6.08,13]octadeca-1(18),2,4,6,8,10,12,14,16-nonaene Chemical compound N1=CC=C2C3=C(C4=C(C=C12)C=CC=C4)C=CC=C3 ORXLWJFOESJIGJ-UHFFFAOYSA-N 0.000 title 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 239000013067 intermediate product Substances 0.000 title 1
- 102000003390 tumor necrosis factor Human genes 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HR20020440A HRP20020440B1 (en) | 2002-05-21 | 2002-05-21 | 1-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE369371T1 true ATE369371T1 (de) | 2007-08-15 |
Family
ID=29433922
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03752868T ATE369371T1 (de) | 2002-05-21 | 2003-05-20 | 1-azadibenzoazulene als inhibitoren der produktion von tumornekrosefaktor und zwischenprodukte für deren herstellung |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US7312203B2 (de) |
| EP (1) | EP1506202B1 (de) |
| JP (1) | JP2005534637A (de) |
| CN (1) | CN1310919C (de) |
| AR (1) | AR040086A1 (de) |
| AT (1) | ATE369371T1 (de) |
| AU (1) | AU2003232373A1 (de) |
| CA (1) | CA2485212A1 (de) |
| DE (1) | DE60315448T2 (de) |
| ES (1) | ES2290492T3 (de) |
| HR (1) | HRP20020440B1 (de) |
| IS (1) | IS7569A (de) |
| PL (1) | PL374342A1 (de) |
| RS (1) | RS99504A (de) |
| WO (1) | WO2003097648A1 (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP20020304B1 (en) * | 2002-04-10 | 2008-04-30 | GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. | 1-oxa-3-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the production thereof |
| HRP20020441A2 (en) * | 2002-05-21 | 2003-12-31 | Pliva D D | 1-oxa-dibenzoazulen as inhibitor of production of tumor necrosis factors and intermediate for preparation thereof |
| HRP20020440B1 (en) | 2002-05-21 | 2008-02-29 | GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. | 1-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof |
| HRP20020452A2 (en) | 2002-05-23 | 2004-02-29 | Pliva D D | 1,2-diaza-dibenzoazulen as inhibitor of production of tumor necrosis factors and intermediates for preparation thereof |
| HRP20030160A2 (en) * | 2003-03-06 | 2005-04-30 | Pliva-Istra�iva�ki institut d.o.o. | 1-thiadibenzoazulene derivatives and biological action thereof |
| HRP20030955A2 (en) * | 2003-11-21 | 2005-08-31 | Pliva-Istra�iva�ki institut d.o.o. | USE OF 1-OXADIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS |
| HRP20030956A2 (en) * | 2003-11-21 | 2005-08-31 | Pliva-Istra�iva�ki institut d.o.o. | USE OF 1,2-DIAZA-DIBENZO[e,h]AZULENES FOR THE MANU |
| HRP20030954A2 (en) * | 2003-11-21 | 2005-08-31 | Pliva D.D. | USE OF 1-AZA-DIBENZO[e,h]AZULENES FOR THE MANUFACTURENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS |
| HRP20040104A2 (en) * | 2004-01-30 | 2005-10-31 | Pliva-Istra�iva�ki institut d.o.o. | Use of benzonaphthoazulenes for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders |
| JP2008532927A (ja) * | 2005-01-13 | 2008-08-21 | グラクソスミスクライン・イストラジヴァッキ・センタル・ザグレブ・ドルズバ・ゼー・オメイェノ・オドゴヴォルノスティオ | 抗炎症マクロライド接合体 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH532038A (de) | 1970-05-25 | 1972-12-31 | Ciba Geigy Ag | Verfahren zur Herstellung von neuen Cycloheptenderivaten |
| US3859439A (en) | 1970-05-26 | 1975-01-07 | Ciba Geigy Corp | 2,3-dihydro-5 -trifluoromethyl-1h-dibenzo(2,3:6,7) thiepino (4,5-c) pyrroles as cns-depressants |
| US3711489A (en) * | 1971-03-31 | 1973-01-16 | Pfizer | Certain 8,9-dihydro(3,4,7,8)cycloocta(1,2-d)imidazoles |
| CA967573A (en) | 1972-12-22 | 1975-05-13 | Joseph G. Lombardino | Tetracyclic anti-inflammatory agents |
| US4112110A (en) | 1974-02-22 | 1978-09-05 | Ciba-Geigy Corporation | Oxygenated azatetracyclic compounds |
| US4189421A (en) * | 1975-04-10 | 1980-02-19 | The Sherwin-Williams Company | Crosslinking agent for powder coatings |
| US4271179A (en) | 1976-05-24 | 1981-06-02 | Akzona Incorporated | 1,2,3,3a,8,12b-Hexahydro-dibenzo[1,2;5,6]cyclohepta[3,4-C]pyrroles and pharmaceutical use thereof |
| US4198421A (en) | 1978-11-30 | 1980-04-15 | E. I. Du Pont De Nemours And Company | Antiinflammatory 2-substituted-dibenzo[2,3:6,7]oxepino[4,5-d]imidazoles |
| US4267184A (en) | 1979-02-08 | 1981-05-12 | E. I. Du Pont De Nemours And Company | Antiinflammatory 4,5-diaryl-2-(substituted-thio)pyrroles and their corresponding sulfoxides and sulfones |
| US4267190A (en) | 1980-04-18 | 1981-05-12 | E. I. Du Pont De Nemours And Company | Antiinflammatory 4,5-diaryl-α,α-bis(polyfluoromethyl)-1H-pyrrole-2-methanethiols |
| FI841399L (fi) | 1983-04-12 | 1984-10-13 | Ciba Geigy Ag | Polycykliska karboxylsyrafoereningar, foerfarande foer deras framstaellning och dessa karboxylsyrafoereningar innehaollande preparat samt deras anvaendning. |
| IE62754B1 (en) | 1988-08-26 | 1995-02-22 | Akzo Nv | Tetracyclic antidepressants |
| CA2003283A1 (en) | 1988-12-05 | 1990-06-05 | C. Anne Higley | Imidazoles for the treatment of atherosclerosis |
| US5166214A (en) | 1988-12-05 | 1992-11-24 | Du Pont Merck Pharmaceutical Company | Use of imidazoles for the treatment of atherosclerosis |
| WO1998054186A1 (en) | 1997-05-26 | 1998-12-03 | Akzo Nobel N.V. | Salts of aromatic sulphonic acids |
| HRP20000310A2 (en) | 2000-05-17 | 2002-02-28 | Pliva Farmaceutska Ind Dioniko | New dibenzoazulene compounds as tumor necrosis factor inhibitors |
| HRP20020440B1 (en) * | 2002-05-21 | 2008-02-29 | GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. | 1-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof |
-
2002
- 2002-05-21 HR HR20020440A patent/HRP20020440B1/xx not_active IP Right Cessation
-
2003
- 2003-05-20 CA CA002485212A patent/CA2485212A1/en not_active Abandoned
- 2003-05-20 PL PL03374342A patent/PL374342A1/xx not_active Application Discontinuation
- 2003-05-20 RS YU99504A patent/RS99504A/sr unknown
- 2003-05-20 US US10/515,679 patent/US7312203B2/en not_active Expired - Fee Related
- 2003-05-20 CN CNB038167077A patent/CN1310919C/zh not_active Expired - Fee Related
- 2003-05-20 AU AU2003232373A patent/AU2003232373A1/en not_active Abandoned
- 2003-05-20 WO PCT/HR2003/000026 patent/WO2003097648A1/en not_active Ceased
- 2003-05-20 JP JP2004505380A patent/JP2005534637A/ja active Pending
- 2003-05-20 DE DE60315448T patent/DE60315448T2/de not_active Expired - Fee Related
- 2003-05-20 EP EP03752868A patent/EP1506202B1/de not_active Expired - Lifetime
- 2003-05-20 AT AT03752868T patent/ATE369371T1/de not_active IP Right Cessation
- 2003-05-20 ES ES03752868T patent/ES2290492T3/es not_active Expired - Lifetime
- 2003-05-21 AR ARP030101758A patent/AR040086A1/es not_active Application Discontinuation
-
2004
- 2004-11-22 US US10/995,955 patent/US20050148578A1/en not_active Abandoned
- 2004-11-29 IS IS7569A patent/IS7569A/is unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IS7569A (is) | 2004-11-29 |
| EP1506202B1 (de) | 2007-08-08 |
| ES2290492T3 (es) | 2008-02-16 |
| EP1506202A1 (de) | 2005-02-16 |
| JP2005534637A (ja) | 2005-11-17 |
| DE60315448T2 (de) | 2008-05-08 |
| US20050209191A1 (en) | 2005-09-22 |
| CN1668622A (zh) | 2005-09-14 |
| HRP20020440A2 (en) | 2004-06-30 |
| HK1081953A1 (en) | 2006-05-26 |
| HRP20020440B1 (en) | 2008-02-29 |
| RS99504A (sr) | 2006-10-27 |
| AR040086A1 (es) | 2005-03-16 |
| DE60315448D1 (de) | 2007-09-20 |
| US7312203B2 (en) | 2007-12-25 |
| WO2003097648A1 (en) | 2003-11-27 |
| AU2003232373A1 (en) | 2003-12-02 |
| CA2485212A1 (en) | 2003-11-27 |
| US20050148578A1 (en) | 2005-07-07 |
| CN1310919C (zh) | 2007-04-18 |
| PL374342A1 (en) | 2005-10-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE502005009089D1 (de) | 1-methyl-3-trifluormethyl-pyrazol-4-carbonsäure-(ortho-phenyl)-anilide und ihre verwendung als fungizid | |
| ATE442348T1 (de) | Amino substituierte phenylessigsäuren sowie deren derivate, deren herstellung und deren verwendung als cyclooxygenase 2 (cox-2) inhibitoren | |
| DE60321043D1 (de) | Biphenylderivate und deren verwendung als fungizide | |
| DE602005027546D1 (de) | Aryl- und heteroarylpiperidincarboxylatderivate, deren herstellung und deren verwendung in form von faah-enzyminhibitoren | |
| ATE346056T1 (de) | Substituierte phenylacetamide und deren verwendung als glucokinaseaktivatoren | |
| ATE339419T1 (de) | Pyrazolenthaltende zusammensetzungen und ihre verwendung als gsk-3 inhibitoren | |
| ATE443048T1 (de) | 4-oxochinolinverbindungen und deren verwendung als hiv-integrase-inhibitoren | |
| IS7749A (is) | Pýrimídínafleiður og notkun þeirra sem CB2 beina | |
| EP1469860A4 (de) | Antikrebskombination und deren verwendung | |
| EP1499186A4 (de) | Verwendung von häm-oxygenase-1 und häm-abbauprodukte | |
| ATE380184T1 (de) | Derivate von alkylpiperazin- und alkylhomopiperazincarboxylaten, verfahren zu deren herstellung und deren verwendung als inhibitoren des faah-enzyms | |
| NO20051281D0 (no) | Sammensetning for anrikning av naeringsmidler | |
| ITBO20020487A0 (it) | Contenitore e metodo per la realizzazione dello stesso | |
| DE60331571D1 (de) | Verfahren zur herstellung von poröser wabenstruktur und wabenkörper | |
| PL1608811T3 (pl) | Wyrób wielowarstwowy i sposób jego wytwarzania | |
| DE60315448D1 (de) | 1-azadibenzoazulene als inhibitoren der produktion von tumornekrosefaktor und zwischenprodukte für deren herstellung | |
| DE60336720D1 (de) | Fluorsulfate von hexafluorisobutylen und dessen höheren homologen und deren derivaten | |
| DE60334632D1 (de) | Mechanolumineszenzstoff und dessen herstellung | |
| DE50305507D1 (de) | Zusammensetzungen zur herstellung von aminoplasterzeugnissen | |
| DE60206289D1 (de) | Verwendung von bibn4096 in kombination mit anderen migränemitteln zur behandlung von migräne | |
| DE60311598D1 (de) | Naphthyridin-derivate und ihre verwendung als fungizide | |
| ATE409191T1 (de) | 1,3-diaza-dibenzoazulene als inhibitoren der produktion von tumornekrosefaktor und zwischenprodukte für deren herstellung | |
| ITMI20022704A1 (it) | Procedimento per la produzione di mesitilene e durene. | |
| ATE343582T1 (de) | Derivate von (6, 7-dihydro -5h-imidazo(1,2 - a)imidazol -3 -sulfonylamino)-propionamid und deren verwendung als inhibitoren der interaktion von cams und leukointreginen | |
| EG24152A (en) | Novel method for the synthesis of s-indoline-2-carboxylic acid and application thereof in synthesis of perindopril |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |